National Healthcare Properties, Inc. NHP
—
16.03
(0.19)
(1.17%)
as of 25 Sep
- Market cap
- $310.6M
- P/E
- 0.0×
Follow NHP
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.62 | 0.99 | 0.99 | 0.99 | |
P/FCF ratio |
0.00 | 13.56 | 13.56 | 13.56 | |
P/Operating CF |
41.76 | 37.73 | 37.73 | 37.73 | |
P/B ratio |
0.85 | 0.57 | 0.57 | 0.57 | |
Price to Tangible BV |
0.85 | 0.57 | 0.57 | 0.57 | |
EV/Sales |
3.68 | 2.63 | 2.63 | 2.63 | |
EV/EBITDA |
15.23 | 11.98 | 11.98 | 11.98 | |
EV/Operating CF |
24.96 | 24.23 | 24.23 | 24.23 | |
EV/FCF |
(20.15) | 35.95 | 35.95 | 35.95 | |
Quick Ratio |
0.79 | 0.23 | 0.23 | 0.18 | |
Current Ratio |
0.79 | 0.23 | 0.23 | 0.18 | |
Net Debt/EBITDA |
7.98 | 20.58 | 44.56 | 11.13 | |
Debt/Assets |
24.31% | 39.33% | 39.09% | 19.33% | |
Debt/Equity |
0.45 | 1.12 | 1.11 | 0.53 | |
Asset Turnover |
0.18 | 0.19 | 0.19 | 0.18 | |
Operating CF/Net income |
(2.65) | (1.19) | (0.38) | (0.64) | |
Capex/Depreciation |
(6.00) | (0.31) | (0.10) | (0.16) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.54% | 6.34% | 10.12% | 6.59% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
1.85% | 0.71% | 2.21% | 1.55% | |
Graham Net Nets |
(0.65) | (2.83) | (2.83) | (2.83) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(10.44%) | (17.80%) | (17.80%) | (17.80%) | |
Free Cash Flow Yield |
(6.96%) | 7.37% | 7.37% | 7.37% | |
Revenue per Share |
1.42 | 3.05 | 2.98 | 3.04 | |
Operating CF per Share |
0.35 | 0.32 | 0.35 | 0.36 | |
Capex per Share |
(1.68) | (0.19) | (0.07) | (0.11) | |
Free Cash Flow per Share |
(1.33) | 0.13 | 0.28 | 0.25 | |
Cash per Share |
4.91 | 3.76 | 3.83 | 3.62 | |
Shareholders Equity per Share |
17.16 | 21.05 | 21.36 | 22.36 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
17.16 | 21.05 | 21.36 | 22.36 | |
Free Cash Flow |
(81.77) | 3.75 | 8.01 | 7.16 | |
Working Capital |
(87.23) | (462.22) | (462.16) | (612.77) | |
Capital Expenditures |
(103.37) | (5.26) | (1.95) | (3.01) | |
Net Current Asset Value |
(587.59) | (963.97) | (968.06) | (972.56) | |
EV/EBIT |
115.28 | 2,353.18 | 2,353.18 | 2,353.18 | |
Capex to Sales |
1.18 | 0.06 | 0.02 | 0.04 | |
Net Profit Margin |
(9.30%) | (8.81%) | (30.75%) | (18.46%) | |
Price to Operating Income |
82.13 | 887.81 | 887.81 | 887.81 | |
| Other line items | |||||
Average Receivables |
29.35 | 29.51 | 29.71 | 27.18 | |
Average Payables |
47.29 | 48.68 | 66.98 | 65.46 | |
Average Assets |
1,867.58 | 1,764.97 | 1,828.90 | 1,868.36 | |
Average Common Equity |
854.78 | 638.26 | 647.25 | 670.40 |
Columns are period end dates